Biotest AG logo

0N70 - Biotest AG Share Price

€30.16 30.2  0.0%

Sector
Healthcare
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1809
Bullish
Bearish
Unlock 0N70 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 01st Jan 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, BiotestAG revenues increased 16% to EUR341.6M. Net loss increasedfrom EUR2.9M to EUR31.7M. Revenues reflect Therapy segmentincrease of 14% to EUR303.7M, Plasma & Services segmentincrease of 44% to EUR33.8M, Eastern and Southern Europesegment increase of 46% to EUR78.7M, Intercontinentalsegment increase of 42% to EUR62.5M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

0N70 Revenue Unlock 0N70 Revenue

Net Income

0N70 Net Income Unlock 0N70 Revenue

Normalised EPS

0N70 Normalised EPS Unlock 0N70 Revenue

PE Ratio Range

0N70 PE Ratio Range Unlock 0N70 Revenue

Dividend Yield Range

0N70 Dividend Yield Range Unlock 0N70 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
0N70 EPS Forecasts Unlock 0N70 Revenue
Profile Summary

Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Directors
Last Annual January 1st, 1970
Last Interim January 1st, 1970
Public Since October 14, 1987
No. of Shareholders: n/a
No. of Employees: 1,871
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange London Stock Exchange
Shares in Issue
Free Float (0.0%)
Eligible for
ISAs
SIPPs
0N70 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to 0N70
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.